Incretin-based therapies: Facing the realities of benefits versus side effects

Harold E. Lebovitz

doi:10.1089/dia.2013.0274

Incretin-based therapies: Facing the realities of benefits versus side effects

Harold E. Lebovitz

Medicine

SUNY Downstate Health Sciences University

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	909-913
Number of pages	5
Journal	Diabetes Technology and Therapeutics
Volume	15
Issue number	11
DOIs	https://doi.org/10.1089/dia.2013.0274
State	Published - Nov 1 2013

Access to Document

10.1089/dia.2013.0274

Cite this

@article{8cd3e7d587f6435296b836f91ec51c90,

title = "Incretin-based therapies: Facing the realities of benefits versus side effects",

author = "Lebovitz, \{Harold E.\}",

year = "2013",

month = nov,

day = "1",

doi = "10.1089/dia.2013.0274",

language = "English",

volume = "15",

pages = "909--913",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

number = "11",

}

TY - JOUR

T1 - Incretin-based therapies

T2 - Facing the realities of benefits versus side effects

AU - Lebovitz, Harold E.

PY - 2013/11/1

Y1 - 2013/11/1

UR - https://www.scopus.com/pages/publications/84887060335

U2 - 10.1089/dia.2013.0274

DO - 10.1089/dia.2013.0274

M3 - Review article

C2 - 24111860

SN - 1520-9156

VL - 15

SP - 909

EP - 913

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

IS - 11

ER -

Incretin-based therapies: Facing the realities of benefits versus side effects

Access to Document

Other files and links

Fingerprint

Cite this